LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:September 13, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorsLast Updated:September 13, 2011Unknown status
Condition(s):Human Immunodeficiency Virus (HIV)Last Updated:July 14, 2022Completed
Condition(s):Safety and PharmacokineticLast Updated:September 21, 2023Completed
Condition(s):Lymphoid Malignancies; Lymphoma; Hodgkin Lymphoma; Non-hodgkin LymphomaLast Updated:January 8, 2021Terminated
Condition(s):Granulin MutationLast Updated:March 23, 2016Unknown status
Condition(s):Leukemia, Lymphocytic, Chronic; Lymphoma, Small LymphocyticLast Updated:August 30, 2005Terminated
Condition(s):MelanomaLast Updated:May 21, 2020Terminated
Condition(s):Lung Cancer; Head and Neck CancerLast Updated:February 4, 2015Completed
Condition(s):Chronic Myeloproliferative NeoplasmsLast Updated:June 15, 2021Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:February 23, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.